Skip to main content

Table 1 Pre-ECLS characteristics

From: Clinical impact of intra-aortic balloon pump during extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock

 

ECLS/IABP (n = 41)

ECLS alone (n = 55)

p value

Age, years

66 (57–74)

64 (54–75)

0.591

Male gender

31 (75.6)

43 (78.2)

0.767

Body mass index, kg/m2

24.0 (22.4-25.5)

22.8 (21.1-25.2)

0.251

Diabetes mellitus

24 (58.5)

35 (63.6)

0.612

Hypertension

21 (51.2)

25 (45.6)

0.576

Dyslipidemia

5 (12.2)

9 (16.4)

0.567

Current smoker

17 (41.5)

22 (40.0)

0.885

Previous myocardial infarction

7 (17.1)

6 (10.9)

0.383

Previous PCI

7 (17.1)

9 (16.4)

0.926

Previous bypass surgery

3 (7.3)

1 (1.8)

0.310

Known peripheral arterial disease

4 (9.8)

3 (5.5)

0.456

Myocardial infarction

  

0.559

  ST-elevation

26 (63.4)

38 (69.1)

 

  Non-ST-elevation

15 (36.6)

17 (30.9)

 

Cardiopulmonary resuscitation

20 (48.8)

41 (74.5)

0.009

Systolic blood pressure, mmHg

78 (70–83)

80 (70–82)

0.868

Diastolic blood pressure, mmHg

49 (40–60)

50 (44–56)

0.906

Heart rate

113 (71–140)

92 (71–107)

0.285

Hemoglobin, g/dL

13.0 (10.6-14.8)

12.5 (10.3-14.4)

0.497

Creatinine, mg/dL

1.26 (1.07-1.78)

1.23 (0.97-1.75)

0.664

Lactate, initial, mmol/L

7.7 (2.7-13.1)

6.1 (3.4-9.5)

0.550

Left ventricular ejection fraction, %

30 (24–38)

40 (25–50)

0.109

Multi-vessel disease

33 (80.5)

36 (65.5)

0.105

Infarct-related artery

  

0.319

  Left main

6 (14.6)

13 (23.6)

 

  Left anterior descending

19 (46.3)

29 (52.7)

 

  Left circumflex

7 (17.1)

4 (7.3)

 

  Right coronary

9 (22.0)

9 (16.4)

 

Treatment strategies

  

0.056

  PCI

33 (80.5)

45 (81.8)

 

  Bypass surgery

7 (17.1)

3 (5.5)

 

  Medical treatment

1 (2.4)

7 (12.7)

 

Use of vasopressor/inotropic agent

41 (100)

54 (98.2)

1.000

  1. Values are median (interquartile range) or n (%).
  2. ECLS, extracorporeal life support; IABP, intra-aortic balloon pump; PCI, percutaneous coronary intervention.